← Leaderboards
Ya-Huei Kuo
Univ Of Massachusetts Med Sch Worcester
$5,324,658
Attributed
$11,343,693
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,343,693 · 5
By mechanism
R01$6,395,665 · 2
U01$4,798,756 · 2
F32$149,272 · 1
Top collaborators
- Guido Marcucci16 shared
- Russell Christian Rockne7 shared
- Le Xuan Truong Nguyen4 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsLeukemiaRelapseAcute Myelocytic LeukemiaMicrornasMouse ModelMalignant NeoplasmsMolecularResistanceHematopoietic Stem CellsLeukemic CellTargeted TreatmentFusion GeneClinicMalignant - DescriptorDesignBiologicalMutationTreatment ResponseAllogenicMaintenanceChemotherapyNovel Therapeutic InterventionDose
Grant awards (24)
Targeting MicroRNAs to Eradicate Leukemia Stem Cells$1,011,514
R01 · FY2025 · CA · contact PI
State-transition and leukemia potential dynamics to inform disease evolution and adaptive therapy$590,960
U01 · FY2025 · CA
Information flow and state transitions at the system and multi-dimensional scales in leukemia progression$623,198
U01 · FY2024 · CA
State-transition and leukemia potential dynamics to inform disease evolution and adaptive therapy$590,960
U01 · FY2024 · CA
Targeting MicroRNAs to Eradicate Leukemia Stem Cells$480,469
R01 · FY2024 · CA · contact PI
Information flow and state transitions at the system and multi-dimensional scales in leukemia progression$700,616
U01 · FY2023 · CA
Targeting MicroRNAs to Eradicate Leukemia Stem Cells$495,641
R01 · FY2023 · CA · contact PI
Information flow and state transitions at the system and multi-dimensional scales in leukemia progression$863,194
U01 · FY2022 · CA
Targeting MicroRNAs to Eradicate Leukemia Stem Cells$505,757
R01 · FY2022 · CA · contact PI
Information flow and state transitions at the system and multi-dimensional scales in leukemia progression$714,914
U01 · FY2021 · CA
Targeting microRNAs to eradicate leukemia stem cells$497,136
R01 · FY2021 · CA · contact PI
Information flow and state transitions at the system and multi-dimensional scales in leukemia progression$714,914
U01 · FY2020 · CA
Targeting microRNAs to eradicate leukemia stem cells$481,146
R01 · FY2020 · CA · contact PI
Targeting microRNAs to eradicate leukemia stem cells$451,666
R01 · FY2019 · CA · contact PI
Targeting microRNAs to eradicate leukemia stem cells$450,769
R01 · FY2018 · CA · contact PI
HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance$317,475
R01 · FY2018 · CA · contact PI
Targeting microRNAs to eradicate leukemia stem cells$434,503
R01 · FY2017 · CA · contact PI
HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance$317,475
R01 · FY2017 · CA · contact PI
HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance$317,475
R01 · FY2016 · CA · contact PI
HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance$317,475
R01 · FY2015 · CA · contact PI
HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance$317,164
R01 · FY2014 · CA · contact PI
Inv(16) mediated acute myeloid leukemia in mouse models$52,048
F32 · FY2006 · CA · contact PI
Inv(16) mediated acute myeloid leukemia in mouse models$49,928
F32 · FY2005 · CA
Inv(16) mediated acute myeloid leukemia in mouse models$47,296
F32 · FY2004 · CA